Philip C. Mack, Ph.D.
Clinical Interests
Dr. Mack conducts molecular biology and molecular pharmacology studies for the UC Davis
Cancer Center, the California Cancer Consortium, and the Southwest Oncology Group. For the
past twelve years, Dr. Mack has conducted basic and translational research, with an emphasis on
lung cancer. His investigations include molecular and cellular effects of novel anticancer agents in
lung cancer models. Dr. Mack is Director of the UC Davis Cancer Center Molecular Pharmacology
shared resource, Director of Basic Sciences for the California Cancer Consortium and Associate
Director of the Southwest Oncology Group Lung Translational Medicine Committee.
Title
Director of Molecular Pharmacology
Professor
Specialty
Department
Division
Clinic
Education
Cancer, Hematology Oncology, Molecular Biology/Medicine
Internal Medicine
Hematology and Oncology
UC Davis Cancer Center
Ph.D., UC Davis, Davis, California, 1997
B.A., UC Santa Cruz, Santa Cruz, California, 1991
Professional Memberships
American Association for Cancer Research
American Society of Clinical Oncology
International Association for the Study of Lung Cancer
Southwest Oncology Group
Honors and Awards
Select Recent Publications
Helen and Christine Landgraf Memorial Research Fund Award, 2002
For a comprehensive list of Dr. Mack's publications, please click here (opens new window).
© 2016 UC Regents